Revvity Revenue 2012-2025 | RVTY
Revvity annual/quarterly revenue history and growth rate from 2012 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Revvity revenue for the quarter ending September 30, 2025 was $0.699B, a 2.18% increase year-over-year.
- Revvity revenue for the twelve months ending September 30, 2025 was $2.813B, a 3.37% increase year-over-year.
- Revvity annual revenue for 2024 was $2.755B, a 0.16% increase from 2023.
- Revvity annual revenue for 2023 was $2.751B, a 16.95% decline from 2022.
- Revvity annual revenue for 2022 was $3.312B, a 13.48% decline from 2021.
|
Revvity Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $2,755 |
| 2023 | $2,751 |
| 2022 | $3,312 |
| 2021 | $3,828 |
| 2020 | $2,663 |
| 2019 | $2,884 |
| 2018 | $2,778 |
| 2017 | $2,257 |
| 2016 | $2,116 |
| 2015 | $2,105 |
| 2014 | $2,070 |
| 2013 | $2,158 |
| 2012 | $2,105 |
| 2011 | $1,919 |
|
Revvity Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $699 |
| 2025-06-30 | $720 |
| 2025-03-31 | $665 |
| 2024-12-31 | $729 |
| 2024-09-30 | $684 |
| 2024-06-30 | $692 |
| 2024-03-31 | $650 |
| 2023-12-31 | $696 |
| 2023-09-30 | $671 |
| 2023-06-30 | $709 |
| 2023-03-31 | $675 |
| 2022-12-31 | $741 |
| 2022-09-30 | $712 |
| 2022-06-30 | $896 |
| 2022-03-31 | $963 |
| 2021-12-31 | $430 |
| 2021-09-30 | $861 |
| 2021-06-30 | $1,228 |
| 2021-03-31 | $1,308 |
| 2020-12-31 | $235 |
| 2020-09-30 | $964 |
| 2020-06-30 | $812 |
| 2020-03-31 | $652 |
| 2019-12-31 | $805 |
| 2019-09-30 | $707 |
| 2019-06-30 | $723 |
| 2019-03-31 | $649 |
| 2018-12-31 | $756 |
| 2018-09-30 | $674 |
| 2018-06-30 | $703 |
| 2018-03-31 | $644 |
| 2017-12-31 | $642 |
| 2017-09-30 | $554 |
| 2017-06-30 | $547 |
| 2017-03-31 | $514 |
| 2016-12-31 | $567 |
| 2016-09-30 | $514 |
| 2016-06-30 | $536 |
| 2016-03-31 | $498 |
| 2015-12-31 | $451 |
| 2015-09-30 | $563 |
| 2015-06-30 | $564 |
| 2015-03-31 | $527 |
| 2014-12-31 | $441 |
| 2014-09-30 | $542 |
| 2014-06-30 | $556 |
| 2014-03-31 | $531 |
| 2013-12-31 | $589 |
| 2013-09-30 | $522 |
| 2013-06-30 | $541 |
| 2013-03-31 | $505 |
| 2012-12-31 | $563 |
| 2012-09-30 | $510 |
| 2012-06-30 | $522 |
| 2012-03-31 | $511 |
| 2011-12-31 | $539 |
| 2011-09-30 | $453 |
| 2011-06-30 | $479 |
| 2011-03-31 | $447 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.755B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $166.692B | 30.61 |
| HCA Healthcare (HCA) | United States | $107.089B | 17.73 |
| CVS Health (CVS) | United States | $99.777B | 11.47 |
| Elevance Health (ELV) | United States | $83.311B | 12.22 |
| Cencora (COR) | United States | $68.838B | 22.19 |
| Natera (NTRA) | United States | $31.987B | 0.00 |
| DiDi Global (DIDIY) | China | $23.485B | 21.70 |
| Labcorp Holdings (LH) | United States | $22.455B | 17.12 |
| Medpace Holdings (MEDP) | United States | $17.208B | 42.72 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.445B | 0.00 |
| Viatris (VTRS) | United States | $14.812B | 5.52 |
| BioMerieux (BMXMF) | France | $14.802B | 0.00 |
| ICON (ICLR) | Ireland | $14.747B | 14.63 |
| Solventum (SOLV) | United States | $13.786B | 13.38 |
| CochLear (CHEOY) | Australia | $11.760B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.813B | 20.82 |
| Avantor (AVTR) | United States | $8.291B | 12.67 |
| Sonic Healthcare (SKHHY) | Australia | $7.752B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.556B | 0.00 |
| HealthEquity (HQY) | United States | $7.294B | 27.27 |
| BrightSpring Health Services (BTSG) | United States | $7.070B | 42.15 |
| Bausch + Lomb (BLCO) | Canada | $6.078B | 39.91 |
| PACS (PACS) | United States | $6.072B | 36.92 |
| Sotera Health (SHC) | United States | $5.449B | 26.27 |
| Alignment Healthcare (ALHC) | United States | $4.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.124B | 54.86 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.277B | 2.40 |
| Progyny (PGNY) | United States | $2.114B | 41.56 |
| Surgery Partners (SGRY) | United States | $2.057B | 26.50 |
| Establishment Labs Holdings (ESTA) | United States | $1.962B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.877B | 11.21 |
| Ardent Health (ARDT) | United States | $1.231B | 4.02 |
| Teladoc Health (TDOC) | United States | $1.115B | 0.00 |
| Nutex Health (NUTX) | United States | $1.080B | 8.26 |
| CareDx (CDNA) | United States | $1.029B | 16.82 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.910B | 14.89 |
| InnovAge Holding (INNV) | United States | $0.794B | 0.00 |
| Embecta (EMBC) | United States | $0.734B | 4.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.706B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| CryoPort (CYRX) | United States | $0.552B | 0.00 |
| Enhabit (EHAB) | United States | $0.532B | 23.91 |
| Strata Critical Medical (SRTA) | United States | $0.515B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.445B | 8.19 |
| Agilon Health (AGL) | United States | $0.423B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.51 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.288B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.279B | 58.75 |
| So-Young (SY) | China | $0.269B | 0.00 |
| KindlyMD (NAKA) | United States | $0.201B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.181B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.046B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.21 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.016B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |